Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Selective inhibition of thromboxane A2 biosynthesis in blood platelets

Abstract

SAMUELSSON'S group1,2 showed that human platelets convert arachidonic acid and prostaglandin (PG) endoperoxides3 to thromboxane A2 (TXA2). TXA2 strongly aggregates platelets1 and contracts vascular strips1,4,5. Vane's group5,6 has identified TXA2 synthetase in platelet microsomes—this enzyme generates TXA2 from PG endoperoxides. Aspirin-like drugs inhibit generation of PGs (refs 7, 8) and TXA2 (ref. 9) in platelets at the early stage of cyclooxygenation of arachidonic acid10,11. It is through this activity that aspirin, indomethacin, naproxen and other acidic anti-inflammatory drugs are anti-aggregatory11,12—they have little or no effect on generation of TXA2 from PG endoperoxides6. We report here that the non-acidic anti-inflammatory compound 2-isopropyl-3-nicotinyl-indole (L 8027) (refs 13, 14) is a selective TXA2, synthetase inhibitor in platelets and a potent anti-aggregatory agent.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Hamberg, M., Svensson, J. & Samuelsson, B. Proc. natn. Acad. Sci. U.S.A. 72, 2994–2998 (1975).

    Article  ADS  CAS  Google Scholar 

  2. Hamberg, M., Svensson, J. & Samuelsson, B. Advances in Prostaglandin and Thromboxane Research 1 (eds Samuelsson, B. & Paoletti, R) 19–27 (Raven, New York, 1976).

    Google Scholar 

  3. Hamberg, M. & Samuelsson, B. Proc. natn. Acad. Sci. U.S.A. 70, 899–903 (1973).

    Article  ADS  CAS  Google Scholar 

  4. Svensson, J., Hamberg, M. & Samuelsson, B. Acta physiol. scand. 94, 222–228 (1975).

    Article  CAS  Google Scholar 

  5. Needleman, P. et al. Nature 261, 558–560 (1976).

    Article  ADS  CAS  Google Scholar 

  6. Moncada, S., Needleman, P., Bunting, S. & Vane, J. R. Prostaglandins 12, 323–336 (1976).

    Article  CAS  Google Scholar 

  7. Vane, J. R. Nature new Biol. 231, 233–235 (1971).

    Article  Google Scholar 

  8. Smith, J. B. & Willis, A. L. Nature new Biol. 231, 235–237 (1971).

    Article  CAS  Google Scholar 

  9. Green, K., Hamberg, M. & Samuelsson, B. Advances in Prostaglandin and Thromboxane Research 1 (eds B. Samuelsson, B. & Paoletti, R.) 47–58 (Raven, New York, 1976).

    Google Scholar 

  10. Flower, R. J. Pharmac. Rev. 26, 33–67 (1974).

    CAS  Google Scholar 

  11. Smith, J. B. & Macfarlane, D. E. The Prostaglandins 2 (ed. Ramwell, P. W.) 293–343 (Plenum, New York, 1974).

    Book  Google Scholar 

  12. Mustard, J. F. & Packham, M. A. Drugs 9, 19–76 (1975).

    Article  CAS  Google Scholar 

  13. Deby, C., Descamps, M., Binon, F. & Bacq, Z. M. C. r. Seanc. Soc. Biol. 165, 2465–2468 (1971).

    CAS  Google Scholar 

  14. Colot, M. et al. Thérapie 28, 775–798 (1973).

    CAS  PubMed  Google Scholar 

  15. Takeguchi, C., Kohno, E. & Sih, C. J. Biochemistry 10, 2372–2376 (1971).

    Article  CAS  Google Scholar 

  16. Gryglewski, R. J. Prostaglandin Synthetase Inhibitors (eds Robinson, H. J. & Vane, J. R.) 33–52 (Raven, New York, 1974).

    Google Scholar 

  17. Bergström, S., Danielsson, H. & Samuelsson, B. Biochim. biophys. Acta 90, 170–180 (1964).

    Google Scholar 

  18. Lands, W. E. M., Lee, P. & Smith, W. Ann. N. Y. Acad. Sci. 180, 107–122 (1971).

    Article  ADS  CAS  Google Scholar 

  19. Bunting, S. Moncada, S. & Vane, J. R. Proc. Br. pharmac. Soc. April, 1976. p.48.

  20. Piper, P. J. & Vane, J. R. Nature 223, 29–35 (1969).

    Article  ADS  CAS  Google Scholar 

  21. Vane, J. R. Br. J. Pharmac. 12, 344–349 (1957).

    CAS  Google Scholar 

  22. Regoli, D. & Vane, J. R. Br. J. Pharmac. 23, 351–359 (1964).

    CAS  Google Scholar 

  23. Vane, J. R. Br. J. Pharmac. 23, 369–373 (1964).

    Google Scholar 

  24. Gilmore, N., Vane, J. R. & Wyllie, J. H. Nature 218, 1135–1140 (1968).

    Article  ADS  CAS  Google Scholar 

  25. Bundy, G. L. Tetrahedron Lett. 24, 1957–1960 (1975).

    Article  Google Scholar 

  26. Malmsten, C. Life Sci. 18, 169–176 (1976).

    Article  CAS  Google Scholar 

  27. Moncada, S., Gryglewski, R., Bunting, S. & Vane, J. R. Nature 263, 663–665 (1976).

    Article  ADS  CAS  Google Scholar 

  28. Gryglewski, R., Bunting, S., Moncada, S., Flower, R. J. & Vane, J. R. Prostaglandins 12, 685–713 (1976).

    Article  CAS  Google Scholar 

  29. Moncada, S., Gryglewski, R., Bunting, S. & Vane, J. R. Prostaglandins 12, 715–733 (1976).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

GRYGLEWSKI, R., ZMUDA, A., KORBUT, R. et al. Selective inhibition of thromboxane A2 biosynthesis in blood platelets. Nature 267, 627–628 (1977). https://doi.org/10.1038/267627a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/267627a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing